IDEXX LABORATORIES INC /DE Sales-type Lease, Lease Receivable
IDEXX LABORATORIES INC /DE (IDXX) had Sales-type Lease, Lease Receivable of $20.70 million as of 2023-09-30, per its 10-Q filed 2023-11-01.
Discontinued › Notes › Leases
us-gaap:SalesTypeLeaseLeaseReceivable · last filed 2023-11-01
- 2023-09-30: Sales-type Lease, Lease Receivable $20.70M.
- 2023-06-30: Sales-type Lease, Lease Receivable $19.70M.
- 2023-03-31: Sales-type Lease, Lease Receivable $20.30M.
- 2022-12-31: Sales-type Lease, Lease Receivable $18.40M.
| Period end | Sales-type Lease, Lease Receivable |
|---|---|
| 2023-09-30 | $20.70M 10-Q · filed 2023-11-01 |
| 2023-06-30 | $19.70M 10-Q · filed 2023-08-01 |
| 2023-03-31 | $20.30M 10-Q · filed 2023-05-02 |
| 2022-12-31 | $18.40M 10-Q · filed 2023-11-01 |
| 2022-09-30 | $16.40M 10-Q · filed 2022-11-01 |
| 2022-06-30 | $15.80M 10-Q · filed 2022-08-02 |
| 2022-03-31 | $16.10M 10-Q · filed 2022-05-04 |
| 2021-12-31 | $15.30M 10-K · filed 2023-02-16 |
| 2021-09-30 | $14.30M 10-Q · filed 2021-11-02 |
| 2021-06-30 | $13.00M 10-Q · filed 2021-07-30 |
| 2021-03-31 | $11.80M 10-Q · filed 2021-05-04 |
| 2020-12-31 | $11.10M 10-K · filed 2022-02-16 |
| 2020-09-30 | $9.20M 10-Q · filed 2020-10-29 |
| 2020-06-30 | $7.90M 10-Q · filed 2020-07-31 |
| 2020-03-31 | $7.70M 10-Q · filed 2020-04-30 |
| 2019-12-31 | $7.20M 10-K · filed 2021-02-12 |
| 2019-09-30 | $4.50M 10-Q · filed 2019-10-31 |
| 2019-06-30 | $2.60M 10-Q · filed 2019-08-01 |
| 2019-03-31 | $1.30M 10-Q · filed 2019-05-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Lantheus Holdings, Inc. (LNTH) | United States | $6.510B | 26.31 |
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Celldex Therapeutics, Inc. (CLDX) | United States | $2.471B | -9.72 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |